<- Go Home
MEDIVATORS Inc.
MEDIVATORS Inc., doing business as Renal Systems, designs, develops, manufactures, and sells medical devices critical to endoscopy and infection prevention and control. Its endoscope reprocessing products include brushes and flushing aids, detergents and wipes, leak testers, automated endoscope reprocessors, endoscope tracking equipment, hookups, high-level disinfectants and test strips, and endoscope transport and storage solutions, as well as neutralizers, filters, and water treatment systems. The company also offers GI physician products that include disposable endoscopes, capsule endoscopy solutions, and endoscopy visualization aids; endoscopy procedure products, including CO2 and irrigation pumps, irrigation tubing, polyp traps, procedure kits, procedure room accessories, rinse and insufflation tubing, and single-use valves; scientific and surgical products; renal systems, which include hemodialysis concentrates, dialyzer reprocessing, cold sterilants, test strips and test kits, cleaners and disinfectants, autodilutors, and treatment supplies; therapeutic technologies; and sterilization solutions. In addition, it provides services that include decontamination, repair, technical support, equipment installation, and education and training, as well as assistance in the areas of research and development, product design, packaging, product validation, regulatory support, and marketing support. The company offers its products for clinics and hospitals through distributors in the United States and internationally. MEDIVATORS Inc. was formerly known as Minntech Corporation and changed its name to MEDIVATORS Inc. in May 2012. The company was incorporated in 1974 and is based in Minneapolis, Minnesota. It has locations in Conroe, Texas; Heerlen, the Netherlands; Singapore; Shanghai, China; and Stafford, United Kingdom. As of July 9, 2001, MEDIVATORS Inc. operates as a subsidiary of Steris Dover Limited.
Market Cap
$68.8M
Volume
31.0K
Cash and Equivalents
$15.8M
EBITDA
$7.8M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$29.1M
Profit Margin
36.85%
52 Week High
$10.95
52 Week Low
$5.63
Dividend
N/A
Price / Book Value
1.27
Price / Earnings
19.43
Price / Tangible Book Value
1.29
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$4.3M
Return on Equity
6.64%
Return on Assets
4.29
Cash and Short Term Investments
$15.8M
Debt
N/A
Equity
$54.5M
Revenue
$78.9M
Unlevered FCF
$4.2M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium